Targeted replacement of human γδ TCR in mice enhances antigen-specific B cell immunity - Summary - MDSpire

Targeted replacement of human γδ TCR in mice enhances antigen-specific B cell immunity

  • By

  • Husheem Michael

  • Michael Pitre

  • Gene W. Weng

  • Mikaela M. Vallas

  • Ellen Chen

  • Paul Sheiffele

  • Wei Weng

  • June 17, 2026

  • 0 min

Share

Objective:

To assess the adaptive and humoral immune responses, including specific antibody production and B cell activation, of γδ HuTCR-T1 mice compared with wild-type mice following immunization with collagen and keratin antigens.

Approach:
    Key Findings:
    • γδ HuTCR-T1 mice showed significantly increased antigen-specific antibody-secreting cells.
    • Elevated serum levels of antigen-specific IgG, IgA, and IgE were observed.
    • Expansion of plasma and memory B cell populations was noted in spleen and blood.
    • A distinct cytokine profile was identified, with increased production of IL-4, IL-6, IL-10, IL-17, TGFβ, IFNγ, and TNFα.
    • Serum levels of anti-ANA antibodies remained below detection threshold.
    Interpretation:

    Human γδ T cells enhance adaptive and humoral immunity through direct interactions and cytokine-driven mechanisms that promote B cell maturation and activation, suggesting potential therapeutic avenues in immunotherapy.

    Limitations:
    • The study was conducted in a mouse model, which may not fully replicate human immune responses, limiting the direct applicability of findings.
    • Further research is needed to explore the long-term effects of γδ T cell modulation on B cell responses and their implications for human health.
    Conclusion:

    The findings highlight the role of human γδ T cells in regulating immune responses and support the utility of the γδ HuTCR-T1 model for preclinical studies, paving the way for future research in immunotherapy.

Original Source(s)

Related Content